The Technical Analyst
Motus GI Holdings Inc [MOTS]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Motus GI Holdings Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
-8.98% $0.0760
America/New_York / 17 apr 2024 @ 15:59
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 0.396 mill |
| EPS: | -15.89 |
| P/E: | 0 |
| Earnings Date: | May 08, 2024 |
| SharesOutstanding: | 5.21 mill |
| Avg Daily Volume: | 1.687 mill |
| RATING 2024-04-17 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Buy | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ -0.0060 - 0.158 ( +/- 107.89%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-05 | Durbin Scott | Buy | 23 205 | Stock Option (right to buy) |
| 2024-03-05 | Nelson Sonja | Buy | 23 205 | Stock Option (right to buy) |
| 2024-03-05 | Pruden Gary J | Buy | 23 205 | Stock Option (right to buy) |
| 2024-03-05 | Moran Timothy P. | Buy | 23 205 | Stock Option (right to buy) |
| 2023-09-12 | Orchestra Biomed Holdings, Inc. | Sell | 0 | Common Stock |
| INSIDER POWER |
|---|
| 90.95 |
| Last 97 transactions |
| Buy: 3 737 850 | Sell: 1 627 604 |
Forecast:
16:00 - $0.0760
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $0.0760
Forecast 2: 16:00 - $0.0760
Forecast 3: 16:00 - $0.0760
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.0760 (-8.98% ) |
| Volume | 0.661 mill |
| Avg. Vol. | 1.687 mill |
| % of Avg. Vol | 39.20 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MOTS
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
MOTS
Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.
Latest Press Releases
2024-03-18 16:05:00 - Press Release
Motus Gi Reports Fourth Quarter And Full Year 2023 Financial Results And Provides Corporate Update
Fort lauderdale, fla., march 18, 2024 (globe newswire) -- motus gi holdings, inc., (nasdaq: mots) (“motus gi” or the “company”), a medical technology company focused on improving endoscopic outcomes and experiences, today reported its financial results for the fourth quarter and year ended december 31, 2023, and provided a corporate update.
2024-02-29 07:57:00 - Press Release
Endosound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr As Chief Executive Officer
Portland, ore.--(business wire)--endosound™ inc., a pioneering medical technology company dedicated to advancing patient care, is pleased to announce the appointment of scott aldrich jr as chief executive officer on february 1st, 2024. mr aldrich is joining endosound from motusgi (nasdaq: mots) where he served as vice president of commercial and strategy. stephen steinberg md will remain on the executive leadership team as chief medical officer. mr aldrich brings operational and commercial lead.
2024-02-22 08:00:00 - Press Release
Motus Gi Holdings, Inc. Announces Exercise Of Warrants For $2.7 Million Gross Proceeds
Fort lauderdale, fla., feb. 22, 2024 (globe newswire) -- motus gi holdings, inc. (nasdaq: mots, or “motus” or “the company”), a medical technology company focused on improving endoscopic outcomes and experiences, today announced that it has entered into a definitive agreement for the immediate exercise of an outstanding series b common stock purchase warrant held by an institutional investor to purchase an aggregate of 2,933,334 shares of the company's common stock for gross proceeds to the company of approximately $2.7 million.
2024-02-21 08:52:00 - Press Release
Motus Gi Holdings Granted A U.s. Patent For A Key Feature Embodied By The Pure-vu® System To Avoid Clogging In Cleansing The Gi Tract
Fort lauderdale, fla., feb. 21, 2024 (globe newswire) -- motus gi holdings, inc. (“the “company”) (nasdaq: mots), a medical technology company focused on improving endoscopic outcomes and experiences, today announced that the united states patent and trademark office (uspto) has issued the company a new patent (patent # 11904085) titled, “colon cleaning system with automatic self-purging feature.”
2024-02-16 16:15:00 - Press Release
Motus Gi Holdings, Inc. Announces Adjournment Of The February 16, 2024 Special Meeting Of Stockholders
Fort lauderdale, fla., feb. 16, 2024 (globe newswire) -- motus gi holdings, inc. (“the company”) (nasdaq: mots), today announced that its special meeting of stockholders held on february 16, 2024 (the “special meeting”) was convened and then adjourned, without conducting any business, in order to provide stockholders additional time within which to vote on the proposal described in the company's definitive proxy statement filed with the securities and exchange commission (the “sec”) on january 24, 2024 (the “proxy statement”).
Latest News
2024-04-12 08:32:52 - InvestorPlace
Why Is Motus GI (MOTS) Stock Down 37% Today?
Motus GI (NASDAQ: MOTS ) stock is falling on Friday following a warning that the medical technology company is in danger of being delisted. Motus GI got a delisting notice from the Listing Qualifications Staff of the Nasdaq Exchange on April 5.
2024-02-05 09:06:03 - Zacks Investment Research
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Lancaster Colony (LANC), On Holding (ONON), Rent the Runway (RENT), 5E Advanced Materials (FEAM) and Motus GI (MOTS).
2023-12-19 08:40:03 - InvestorPlace
Why Is Motus GI (MOTS) Stock Down 44% Today?
Motus GI (NASDAQ: MOTS ) stock is falling on Tuesday after the medical technology company announced the pricing of its shares in a public offering. This has the company offering 3,333,334 shares of MOTS stock for $1.50 per share.
2023-08-24 16:05:00 - GlobeNewsWire
Motus GI to Present at the H.C. Wainwright 25th Annual Global Investment Conference
FORT LAUDERDALE, Fla., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and experiences, announced today that Mark Pomeranz, President and Chief Executive Officer, will present at the H.C. Wainwright 25th Annual Global Investment Conference.
2023-07-21 08:27:21 - Zacks Investment Research
New Strong Buy Stocks for July 21st
TRDA, LPRO, TBBK, BMTX and MOTS have been added to the Zacks Rank #1 (Strong Buy) List on July 21, 2023.
2023-05-19 09:07:52 - InvestorPlace
Why Is Motus GI (MOTS) Stock Down Today?
Motus GI (NASDAQ: MOTS ) stock is slipping on Friday after the medical technology company announced a private placement. This has Motus GI offering 4,142,012 shares of MOTS stock for $0.845 each.
2023-05-10 20:31:19 - Zacks Investment Research
Motus GI Holdings, Inc. (MOTS) Reports Q1 Loss, Lags Revenue Estimates
Motus GI Holdings, Inc. (MOTS) came out with a quarterly loss of $0.65 per share versus the Zacks Consensus Estimate of a loss of $1.06. This compares to loss of $1.80 per share a year ago.
2023-03-31 19:05:50 - Zacks Investment Research
Motus GI Holdings, Inc. (MOTS) Reports Q4 Loss, Lags Revenue Estimates
Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 36.80% and 72.75%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
2022-11-14 21:03:30 - Zacks Investment Research
Motus GI Holdings, Inc. (MOTS) Reports Q3 Loss, Misses Revenue Estimates
Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 9.63% and 14.72%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
2022-11-14 18:44:02 - Seeking Alpha
Motus GI Holdings, Inc. (MOTS) Q3 2022 Earnings Call Transcript
Motus GI Holdings, Inc. (NASDAQ:MOTS ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Garth Russell - Managing Director-LifeSci Advisors, LLC Tim Moran - Chief Executive Officer Andrew Taylor - Chief Financial Officer Mark Pomeranz - President & Chief Operating Officer Conference Call Participants Steve Lichtman - Oppenheimer and Co. Ben Haynor - Alliance Global Partners Operator Ladies and gentlemen, thank you for standing by, and welcome to the Motus GI Holdings, Inc. Third Quarter 2022 Financial and Operational Update. At this time, all participants are in a listen-only mode.